Cureus, 2025 · DOI: 10.7759/cureus.79367 · Published: February 20, 2025
Spinal cord injuries (SCI) cause both immediate and subsequent damage. Microglia, the immune cells in the central nervous system, respond to SCI in ways that can worsen the injury. Nuclear factor kappa B (NF-kB) is a key player in controlling inflammation after SCI. This review explains how NF-kB affects microglia's response after SCI. Targeting NF-kB in microglia might help reduce inflammation and protect nerve tissue after SCI, offering a potential therapeutic approach.
Modulating NF-kB signaling in microglia presents a potential therapeutic target for mitigating inflammation, promoting neuroprotection, and facilitating tissue repair following spinal cord injury.
Deactivation of the NF-kB signaling pathway can suppress the production of proinflammatory mediators in microglia post-SCI, aiding in inflammation control.
NF-kB suppression exhibits neuroprotective properties by reducing neuronal apoptosis and fostering the M2 microglial phenotype, thereby diminishing tissue damage after SCI.